Alaunos Therapeutics Inc (TCRT : NASDAQ)
Common Stock
$1.05
USD
+0.26 (32.91%)
Last updated: 2026-10-12
Follow TCRT
TCRT
Alaunos Therapeutics Inc
WealthAwesomePerformance
1 Day
+32.91%
1 Week
+32.03%
1 Month
-30.46%
YTD
-52.70%
Key Statistics
Market Cap
$2.30M
52W High
$4.50
52W Low
$0.72
P/E Ratio
-
50 Day MA
$1.51
200 Day MA
$2.39
Beta
-0.87
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/12/2026 | $0.78 | $1.05 | $0.77 | $1.05 | $1.05 | 3,405,000 |
| 10/9/2026 | $0.80 | $0.80 | $0.78 | $0.79 | $0.79 | 49,700 |
| 10/8/2026 | $0.84 | $0.85 | $0.78 | $0.78 | $0.78 | 89,931 |
| 10/7/2026 | $0.74 | $0.89 | $0.72 | $0.84 | $0.84 | 308,168 |
| 10/6/2026 | $0.79 | $0.82 | $0.72 | $0.74 | $0.74 | 121,100 |
| 10/5/2026 | $0.81 | $0.82 | $0.78 | $0.80 | $0.80 | 48,122 |
| 10/2/2026 | $0.90 | $0.94 | $0.82 | $0.82 | $0.82 | 86,500 |
| 10/1/2026 | $0.91 | $0.95 | $0.89 | $0.92 | $0.92 | 39,945 |
| 9/30/2026 | $0.95 | $1.00 | $0.85 | $0.89 | $0.89 | 90,034 |
| 9/29/2026 | $1.03 | $1.05 | $0.96 | $0.96 | $0.96 | 36,523 |
Analyst Price Targets
Based on analyst covering TCRT · as of Oct 5, 2026
Wall Street analysts forecast TCRT stock price to rise 66.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$1.75
+66.7% Upside
Current Price
US$1.05
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TCRT's historical volatility
30-Day Vol
159.9%
Annualized
90-Day Vol
105.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.88
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.99 | US$0.57 – US$1.72 |
| 60 trading days | US$0.93 | US$0.43 – US$2.03 |
| 90 trading days | US$0.88 | US$0.34 – US$2.28 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Financials
- Revenue (TTM)
- $3,000
- EBITDA
- $-4.03M
- Profit Margin
- 0.00%
- ROE (TTM)
- -185.95%
- EPS (Diluted)
- -1.76
- Book Value
- 0.26
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About TCRT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| MNDR | Mobile-health Network Solutions Class A Ordinary Shares | $3.04 | +257.65% |
| LNKS | Linkers Industries Limited Class A Ordinary Shares | $2.27 | +138.37% |
| YMAT | J-Star Holding Co., Ltd. Ordinary Shares | $2.91 | +125.58% |
| CLWT | Euro Tech Holdings Company Ltd | $2.15 | +58.09% |
| BMBL | Bumble Inc | $3.80 | +49.61% |
| SKYA | SkyAI, Inc. | $2.60 | +42.86% |
| WFF | WF Holding Limited Ordinary Shares | $17.28 | +40.60% |
| NCPL | Netcapital Inc | $1.54 | +35.09% |